IDEAYA Biosciences (IDYA) Stock Insights
IDYA$32.89-1.07 -3.15%
$3.17B
Market Cap
-18.08
P/E
102.78
Forward P/E
—
Score
IDYA price $32.89 -1.07 -3.15%
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 19538000 | 27941000 | 50931000 | 23385000 | 7000000 | 218710000 |
IDEAYA Biosciences, Inc. is a precision oncology company primarily dedicated to identifying and advancing targeted therapies, particularly leveraging the concept of synthetic lethality. The firm aims to develop specific treatments for patient groups selected through molecular diagnostic methods. At the forefront of its clinical efforts are two investigational drugs. IDE397, a methionine adenosyltransferase 2a…
Insights · Dividends · Forecast · Financials · Learn
$3.17B
Market Cap
-18.08
P/E
102.78
Forward P/E
—
Score